GlassScriptPhysician profile
Erin M Simpson
NPI 1700299419
$4,618.52
in general payments reported to CMS, 2019-2025
36 companies · $980 in 2025
The $980 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $1,226 · 2023: $1,039 · 2024: $1,075 · 2025: $980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,093.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,083.22 | 2022-2025 | |
| Glaxosmithkline, LLC. | $549.49 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $455.84 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $392.63 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Sanofi-Aventis U.S. LLC | $328.86 | 2021-2023 | |
| Pfizer INC. | $278.50 | 2022-2025 | |
| Axsome Therapeutics, INC. | $204.08 | 2024-2025 | Auvelity |
| Novo Nordisk INC | $202.64 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $142.48 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.11 | 2021-2025 | Xifaxan, Trulance |
| Dexcom, INC. | $106.71 | 2024 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $86.24 | 2024-2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.14 | 2022-2024 | Ofev, Jardiance |
| Amarin Pharma, INC. | $63.51 | 2022 | |
| Amgen INC. | $52.79 | 2022-2025 | Repatha, Otezla |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.